1. Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016
- Author
-
Kathryn S. Czepiel, Mechelle D. Claridy, Fatima Cody Stanford, and Simar Singh Bajaj
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Office Visits ,Logistic regression ,Article ,Young Adult ,Pharmacotherapy ,medicine ,Animals ,Humans ,Obesity ,Practice Patterns, Physicians' ,Medical prescription ,Office based ,business.industry ,General Medicine ,Odds ratio ,Middle Aged ,medicine.disease ,United States ,Logistic Models ,Health Care Surveys ,Family medicine ,Ambulatory ,Female ,Anti-Obesity Agents ,business ,Body mass index - Abstract
OBJECTIVE: To examine the use of pharmacotherapy in obesity treatment in the United States from 2011 to 2016 using a large, nationally representative sample. PATIENTS AND METHODS: Data were obtained over six years, 2011 to 2016, from the National Ambulatory Medical Care Survey. There were three types of visits identified: patients with obesity and an anti-obesity drug mention, patients with obesity and no anti-obesity drug mention, and patients without obesity and with anti-obesity drug mention. Chi-square tests were used to compare characteristics across each type of visit. To predict the odds of an anti-obesity medication mention for patients with obesity, a logistic regression analysis was conducted. RESULTS: Of the overall weighted 196,872,870 office-based physician visits made by patients with obesity from 2011 to 2016, one percent mentioned an anti-obesity drug. Additionally, there were 760,470 office-based physician visits by patients without obesity but with an anti-obesity medication mention. An anti-obesity drug mention was more likely for those ages 51 or older and those residing in the South (AOR: 5.31 95% CI: 1.19-23.59). CONCLUSION: There was a slight increase in anti-obesity medication mentions, from 0.26% in 2011 to 0.28% in 2016, but only one percent of office-based visits for patients with obesity received a prescription for an anti-obesity medication. Physicians tended to prescribe anti-obesity medications to those with obesity ages 51 or older and residing in the South. Anti-obesity medication as treatment for obesity is significantly underutilized.
- Published
- 2021
- Full Text
- View/download PDF